Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Fda    symbols : EBS    save search

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
Published: 2023-07-20 (Crawled : 22:00) - globenewswire.com
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 7.22% H: 4.76% C: -0.79%

av7909 fda anthrax vaccine approval
U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
Published: 2023-03-29 (Crawled : 14:00) - globenewswire.com
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 19.78% H: 0.38% C: -12.29%

narcan fda opioid treatment designation milestone
Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use
Published: 2023-02-15 (Crawled : 23:00) - globenewswire.com
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 8.71% H: 1.85% C: -8.88%

narcan fda spray
Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray
Published: 2022-12-06 (Crawled : 15:00) - biospace.com/
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 2.04% H: 2.08% C: 1.33%

narcan fda drug spray application review
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
Published: 2022-06-24 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: 6.55% H: 0.91% C: -0.27%

av7909 fda candidate vaccine application license
Statement on Issuance of Form FDA 483 at Emergent Bayview Facility
Published: 2021-04-21 (Crawled : 17:00) - globenewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.32% C: 0.13%
EBS | News | $2.29 6.02% 0.0% 860K twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 2.19% C: 1.07%

fda merge
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.